The T.J. Martell Foundation is dedicated to funding innovative cancer research, which is overseen by the Foundation's national Scientific Advisory Committee.
"Without the support of the T.J. Martell Foundation, the innovative breakthroughs that we all deserve and fortunately have come to expect as a return on our investment could not have happened," said Mitchell C. Benson, M.D., Herbert and Florence Irving Professor of Urology at Columbia University Medical Center. "The T.J. Martell Foundation takes educated risks on supporting early-stage research. These risks result in the new understanding of cancer, which leads to new treatments and, ultimately, the great promises of saving lives."
The Scientific Advisory Committee was created by the T.J. Martell Foundation to vet research grant requests, but they function as much more than a clearinghouse for promising research proposals. They are engaged in the process and operate like a think tank, providing valuable insight and direction to researchers from the finest medical facilities in the nation.
The committee includes Carlo Croce (Chair of the Department of Cancer Biology and Genetics at OSU) and Hal Moses (Research Professor of Pharmacology; Professor Emeritus of Cancer Biology; Director Emeritus, Vanderbilt-Ingram Cancer Center); a world-renowned urologist, Mitchell C. Benson (Herbert and Florence Irving Professor of Urology at Columbia University Irving Medical Center); and renowned cardiologist, Randolph P. Martin, M.D., FACC, FASE, FESC (Emeritus Professor of Medicine, Cardiology, Emory University School of Medicine).
The Committee is chaired by world-renowned translational scientist Robert Bast (Vice President of Translational Medicine at the M.D. Anderson Cancer Center).
The T.J. Martell Foundation supports high-risk, high-gain cancer research at NCI-designated flagship hospitals in the United States. The foundation supports great science that progresses and improves year-to-year. Nurturing the next generation of scientists is important to assist with “proof of concept” results necessary to compete for larger NIH grants.
“The T.J. Martell Scientific Advisory Committee includes physicians and scientists with decades of experience in conducting and evaluating research. Their role is to assure that the Foundation invests in the most promising research to benefit cancer patients and that progress is made as promptly as possible,” said Dr. Robert Bast, Vice President of Translational Medicine at MD Anderson Cancer Center and Chairman of the Scientific Advisory Committee.